Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer
NCT04278261 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216
Last updated 2022-06-02
Summary
This trial is comparing the functional and oncological outcomes in treating men with prostate cancer between high-frequency irreversible electroporation and laparoscopic radical prostatectomy.
Conditions
- Prostate Cancer
- Treatment
Interventions
- PROCEDURE
-
Focal therapy(high-frequency irreversible electroporation)
High-frequency irreversible electroporation will be performed via the perineum with the guidance of ultrasound under general anaesthesia to the patient with localized prostate cancer
- PROCEDURE
-
laparoscopic radical prostatectomy
Laparoscopic radical prostatectomy
Sponsors & Collaborators
-
Shanghai East Hospital
lead OTHER
Principal Investigators
-
Haifeng Wang, MD · Shanghai East Hospital,Tongji University School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2026-07-01
- Completion
- 2026-09-01
Countries
- China
Study Locations
More Related Trials
-
Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT
NCT04215510 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Supportive Clinic for Patients Living With Advanced and Metastatic Cancers
NCT06465511 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Novel Therapy Target in Metastatic Prostate Cancer
NCT05577689 ·Status: RECRUITING
-
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
NCT07343791 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Prospective, Randomized, Open, Parallel-controlled, Superior-efficacy Clinical Study of Radical Sigmoidectomy for Sigmoid Cancer Versus Radical Sigmoidectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracing Dissection in the Treatment of Sigmoid Cancer
NCT06396806 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer
NCT02339701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer
NCT04819516 ·Status: RECRUITING ·Phase: PHASE1
-
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
NCT06949098 ·Status: RECRUITING ·Phase: PHASE2
-
Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer
NCT07034742 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC
NCT06992232 ·Status: RECRUITING ·Phase: PHASE2
-
Single-port Robotic Radical Gastrectomy for Gastric Cancer
NCT07237126 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Selective Total Mesorectal Excision Based on Intra-Operative Frozen Section From Local Excision in Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
NCT07337811 ·Status: RECRUITING ·Phase: NA
-
Preoperative Radiotherapy and E7046 in Rectum Cancer
NCT03152370 ·Status: COMPLETED ·Phase: PHASE1
-
PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer
NCT06933251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer
NCT06746298 ·Status: NOT_YET_RECRUITING
-
Intraoperative Radiation Therapy for Resectable Pancreatic Cancer
NCT03273374 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Assessment of IRE of Localized Prostate Cancer
NCT04192890 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Assessment of IRE of Localized Prostate Cancer.
NCT03504995 ·Status: COMPLETED ·Phase: NA
-
Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases
NCT01677728 ·Status: UNKNOWN
-
Functional Organ Preservation Surgery
NCT01330056 ·Status: COMPLETED ·Phase: NA
-
Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery
NCT03221608 ·Status: UNKNOWN ·Phase: PHASE3
-
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
NCT06304987 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC
NCT06599827 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Clinical Trials of CT-guided Percutaneous Irreversible Electroporation(IRE)in the Treatment of Patients With Locally Advanced Tumors
NCT02567734 ·Status: UNKNOWN ·Phase: NA
-
SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer
NCT06908031 ·Status: RECRUITING ·Phase: PHASE2